Kolexia
Heinzlef Olivier
Neurologie
Chi Poissy St Germain Site De Poissy
Poissy, France
188 Activités
304 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose en plaques Sclérose Sclérose en plaques récurrente-rémittente Fatigue Sclérose en plaques chronique progressive COVID-19 Manifestations neurocomportementales Maladie chronique Bactériurie

Industries

Edimark
16 collaboration(s)
Dernière en 2023
Merck-Serono
15 collaboration(s)
Dernière en 2023
Sanofi
15 collaboration(s)
Dernière en 2023
Novartis
12 collaboration(s)
Dernière en 2022

Dernières activités

A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis: An Adaptive Phase 2a/2b, Randomized, Double-Blind, Parallel-Group Study to Investigate the Safety and Efficacy of LY3541860 Compared to Placebo in Slowing the Occurrence of New T1 Gadolinium-Enhancing Lesions in Adult Participants With Relapsing Multiple Sclerosis
Essai Clinique (Lilly)   19 mars 2024
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
JAMA neurology   12 février 2024
TELECOG-MS: Multicentre Randomized Blinded Controlled Study of Specific Telerehabilitation of Multidomain Cognitive Impairment in Multiple Sclerosis Using Mixed Evaluation and Ecological Validity
Essai Clinique (Celgene)   06 février 2024
RESPONSE: French Registry for Monitoring Pregnancies and Children of Women With Multiple Sclerosis Within The Observatoire Français de la Sclérose en Plaque (OFSEP) Cohort
Essai Clinique (Hospices Civils de Lyon)   25 janvier 2024
Evaluation of the quality and the productivity of neuroradiological reading of multiple sclerosis follow-up MRI scans using an intelligent automation software.
Neuroradiology   24 janvier 2024
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
Multiple sclerosis (Houndmills, Basingstoke, England)   21 janvier 2024
Hier, le... - Ligue Française Contre La Sclérose En Plaques
Facebook   30 novembre 2023
STOP-I-SEP: Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years
Essai Clinique (CHU Rennes)   23 octobre 2023
Comparison of Two Methods for Estimating MS-Related Mortality: The Excess Mortality vs. the Cause-Specific Frameworks.
Neurology   12 octobre 2023
POLAR: Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion Among Patients With or Without Lesions at the Magnetic Resonance Imaging (Oligoclonal Profile of Tears)
Essai Clinique (Lille Catholic University)   12 septembre 2023